Previous Article in event
Previous Article in session
Next Article in event
Synthesis and Characterization of Tetrahydroquinolines as Acetylcholinesterase Inhibitors
Published:
31 October 2013
by MDPI
in The 17th International Electronic Conference on Synthetic Organic Chemistry
session General Organic Synthesis
Abstract: Quinoline is a heterocyclic scaffold of paramount importance to human race. Quinolines and their derivatives occur in numerous natural resources. Compounds containing quinoline structure are widely used as antiasthmatic, antimalarials, anti-viral, anti-inflammatory, antibacterials, antifungals, and anticancer (1). Among quinoline derivatives, tetrahydroquinolines (THQs) are an important structural subunit of natural and synthetic products and many THQs derivatives exhibit interesting biological and pharmaceutical activities (2). Many quinoline derivatives have shown anti-cholinesterase activity and can be potential agents for treatment of Alzheimer disease (3-5).In the present study we have synthesized 7 derivatives of THQs with different patterns of substituent using the Povarov reaction in presence of Lewis acid, all compounds was characterized by 1H-NMR, 13C-NMR and Mass Spectra, and evaluated as potentials inhibitors of acetylcholinesterase.
Keywords: Tetrahydroquinolines, Acetylcholinesterase, Povarov Reaction
Comments on this paper
David Mauricio Ramírez Sánchez
20 November 2013
Acetylcholinesterase inhibitors
Quinolines and tetrahydroquinolines compounds are very important
and they have a lot of pharmaceutical applications. They are also
widely used as medicines to treat many pathologies.
I think it is very useful to incorporate this kind of molecules in the
acetylcholinesterase inhibitors line because they can be potential
agents for the treatment of Alzheimer disease.
Further studies that allow to understand more about this
agents are worth to do.
and they have a lot of pharmaceutical applications. They are also
widely used as medicines to treat many pathologies.
I think it is very useful to incorporate this kind of molecules in the
acetylcholinesterase inhibitors line because they can be potential
agents for the treatment of Alzheimer disease.
Further studies that allow to understand more about this
agents are worth to do.